This is the last monitoring report (to 30 June 2017) for the previous ‘Pap test-based’ National Cervical Screening Program, which ceased on 30 November 2017. For women aged 20–69, participation was estimated at 54%–56%, 7 out of every 1,000 women screened had a high-grade abnormality detected before possible progression to cervical cancer, there were 9–10 new cases per 100,000 women, and there were 2 deaths per 100,000 women.